Price
Target price
€31.80
€31.80
-0.610%
-0.2
-0.610%
€35.85
22.07.26 / Tradegate
WKN: A1W2RM / Symbol: AGIO / Name: Agios / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Agios Pharmaceuticals Inc. Stock
The price for the Agios Pharmaceuticals Inc. stock decreased slightly today. Compared to yesterday there is a change of -€0.200 (-0.610%).
With 19 Buy predictions and not the single Sell prediction the community is currently very high on Agios Pharmaceuticals Inc..
As a result the target price of 35 € shows a slightly positive potential of 10.06% compared to the current price of 31.8 € for Agios Pharmaceuticals Inc..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Agios Pharmaceuticals Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Agios Pharmaceuticals Inc. in the next few years
Pros
?
B****
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Agios Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Agios Pharmaceuticals Inc. | -0.610% | -8.621% | -4.790% | -5.917% | 37.069% | 35.897% | -24.609% |
| Ligand Pharmaceuticals | -0.760% | 1.550% | -1.504% | 125.862% | 57.831% | 326.016% | 156.989% |
| United Therapeutics | -0.910% | 0.065% | -2.561% | 78.913% | 8.612% | 109.621% | 197.500% |
| Ionis Pharmaceuticals Inc. | -1.470% | 6.144% | -30.959% | 36.892% | -27.546% | 40.245% | 60.078% |
Comments
Agios Pharmaceuticals (AGIO) had its price target lowered by HC Wainwright from $54.00 to $52.00. They now have a "buy" rating on the stock.
Show more
Ratings data for AGIO provided by MarketBeat
Agios Pharmaceuticals (AGIO) had its price target raised by Truist Financial Corporation from $36.00 to $41.00. They now have a "buy" rating on the stock.
Show more
Ratings data for AGIO provided by MarketBeat
Agios Pharmaceuticals (AGIO) had its price target lowered by Bank of America Corporation from $41.00 to $40.00. They now have a "buy" rating on the stock.
Show more
Ratings data for AGIO provided by MarketBeat
News
Here's Why Shares in Novo Nordisk Rival, Agios Pharmaceutical, Soared This Week
Agios Pharmaceuticals (NASDAQ: AGIO) stock rose by 13.8% during the week through Friday morning. It's a move driven by the Food and Drug Administration's (FDA) announcement that it would grant
Here's Why Agios Pharmaceuticals Stock Soared Today (Hint: It's FDA-Related)
Shares in Agios Pharmaceuticals (NASDAQ: AGIO) were higher by more than 14% as of 11 a.m this morning. The move comes after a very positive development from the Food and Drug Administration (FDA) on
Agios Pharmaceuticals Touts Mitapivat Gains Despite Sickle Cell Pain Miss
Key Points
- Interested in Agios Pharmaceuticals, Inc.? Here are five stocks we like better.
- Agios reported encouraging mitapivat data in thalassemia, saying long-term extension results from
